Koyfin Home > Directory > Health Care > Adverum Biotechnlgs > Cash and Short-Term Investments

Adverum Biotechnlgs Cash and Short-Term Investments Chart (ADVM)

Adverum Biotechnlgs annual/quarterly Cash and Short-Term Investments from 2013 to 2020.
  • Adverum Biotechnlgs Cash and Short-Term Investments for the quarter ending June 06, 2020 was $280m a 42.18% increase of 118m year over year
  • Adverum Biotechnlgs Cash and Short-Term Investments for the last 12 months ending June 06, 2020 was $280m a 42.18% increase of 118m year over year
  • Adverum Biotechnlgs Annual Cash and Short-Term Investments for 2019 was $166m a -23.52% decrease of -39m from 2018
  • Adverum Biotechnlgs Annual Cash and Short-Term Investments for 2018 was $205m a 7.12% increase of 15m from 2017
  • Adverum Biotechnlgs Annual Cash and Short-Term Investments for 2017 was $190m a -16.63% decrease of -32m from 2016
Other Balance Sheet Metrics:
  • Adverum Biotechnlgs Total Assets for the quarter ending September 09, 2018 was $226m a 10.62% increase of 24m year over year
  • Adverum Biotechnlgs Other Liabilities for the quarter ending December 12, 2018 was $2m a -14.42% decrease of 0m year over year
  • Adverum Biotechnlgs Total Equity for the quarter ending September 09, 2018 was $216m a 14.63% increase of 32m year over year
View Chart On Koyfin

Quarterly ADVM Cash and Short-Term Investments Data

06/2020$280m
03/2020$297m
12/2019$166m
09/2019$162m
06/2019$178m
03/2019$189m
12/2018$205m
09/2018$218m
06/2018$235m
03/2018$247m

Annual ADVM Cash and Short-Term Investments Data

2019$166m
2018$205m
2017$190m
2016$222m
2015$259m
2014$159m
2013$1m
2012$0m